These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 22080762)

  • 41. Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation.
    Terazaki H; Ando Y; Nakamura M; Obayashi K; Misumi S; Shoji S; Yamashita S; Nakagawa K; Ishizaki T; Suhr O; Uemoto S; Inomata Y; Tanaka K
    Transplantation; 2001 Jul; 72(2):296-9. PubMed ID: 11477356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis.
    Gustafsson S; Ihse E; Henein MY; Westermark P; Lindqvist P; Suhr OB
    Transplantation; 2012 May; 93(10):1017-23. PubMed ID: 22395298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation.
    González-Duarte A; Soto KC; Martínez-Baños D; Arteaga-Vazquez J; Barrera F; Berenguer-Sanchez M; Cantu-Brito C; García-Ramos G; Estañol Vidal B
    Amyloid; 2012 Dec; 19(4):171-6. PubMed ID: 22928869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transthyretin: Its function and amyloid formation.
    Ueda M
    Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
    Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
    Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.
    Norgren N; Olsson M; Nyström H; Ericzon BG; de Tayrac M; Genin E; Planté-Bordeneuve V; Suhr OB
    Amyloid; 2014 Jun; 21(2):113-9. PubMed ID: 24601850
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
    Théberge R; Connors L; Skinner M; Skare J; Costello CE
    Anal Chem; 1999 Jan; 71(2):452-9. PubMed ID: 9949732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amyloid detection in the transverse carpal ligament of patients with hereditary ATTR V30M amyloidosis and carpal tunnel syndrome.
    Samões R; Taipa R; Valdrez K; Gonçalves I; Melo Pires M; Martins da Silva A; Coelho T
    Amyloid; 2017 Jun; 24(2):73-77. PubMed ID: 28413892
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis and therapeutic approaches to transthyretin amyloidosis.
    Ando Y; Ueda M
    Curr Med Chem; 2012; 19(15):2312-23. PubMed ID: 22471980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains.
    Bergström J; Patrosso MC; Colussi G; Salvadore M; Penco S; Lando G; Marocchi A; Ueda A; Nakamura M; Ando Y
    Amyloid; 2007 Jun; 14(2):141-5. PubMed ID: 17577687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
    Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M
    Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
    Ueda M; Ando Y; Hakamata Y; Nakamura M; Yamashita T; Obayashi K; Himeno S; Inoue S; Sato Y; Kaneko T; Takamune N; Misumi S; Shoji S; Uchino M; Kobayashi E
    Biochem Biophys Res Commun; 2007 Jan; 352(2):299-304. PubMed ID: 17126291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pathogenesis and therapy for transthyretin related amyloidosis].
    Ando Y; Jono H
    Rinsho Byori; 2008 Feb; 56(2):114-20. PubMed ID: 18402051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver transplantation for hereditary transthyretin amyloidosis.
    Suhr OB; Herlenius G; Friman S; Ericzon BG
    Liver Transpl; 2000 May; 6(3):263-76. PubMed ID: 10827225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype.
    Sekijima Y; Campos RI; Hammarström P; Nilsson KP; Yoshinaga T; Nagamatsu K; Yazaki M; Kametani F; Ikeda S
    J Peripher Nerv Syst; 2015 Dec; 20(4):372-9. PubMed ID: 26306725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
    Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
    Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
    Hurshman Babbes AR; Powers ET; Kelly JW
    Biochemistry; 2008 Jul; 47(26):6969-84. PubMed ID: 18537267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of transthyretin variants by sequential proteomic and genomic analysis.
    Bergen HR; Zeldenrust SR; Butz ML; Snow DS; Dyck PJ; Dyck PJ; Klein CJ; O'Brien JF; Thibodeau SN; Muddiman DC
    Clin Chem; 2004 Sep; 50(9):1544-52. PubMed ID: 15217993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in disease.
    Fonseca D; Gilberto S; Ribeiro-Silva C; Ribeiro R; Guinote IB; Saraiva S; Gomes RA; Mateus É; Viana A; Barroso E; Freire AP; Freire P; Cordeiro C; da Costa G
    Biochem J; 2016 Jul; 473(14):2225-37. PubMed ID: 27208169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.